Transferring Your Cancer Care — to Another Hospital Mid-Treatment

It is safe in most situations, provided the transfer is managed carefully. The risk is not the move itself — it is a gap in clinical information reaching the new team, or an unplanned break in treatment. If your full records, tissue blocks, and imaging travel with you, and the new team reviews them before starting anything new, the transfer is unlikely to harm your care. The situations that carry more risk are mid-cycle chemotherapy transfers and moves mid-radiotherapy course, where continuity of the current treatment matters. Tell your new oncologist exactly where in your treatment you are before your first appointment.

Gathering your records takes most of the time. Pathology reports and discharge summaries usually arrive within a few days of a written request. Tissue blocks take longer — allow at least a week for the physical block to transfer between pathology departments. Imaging on CD can sometimes be handed to you the same day. Once your new centre has your complete file, a first proper consultation can usually be arranged within one to two weeks, though this varies by centre and by how urgently your situation is classified. Start gathering records before you confirm the date of your first new appointment.

Usually not, if your original tissue block transfers. A new pathology team reviews the original material in their own laboratory — they do not need a fresh biopsy to do this. A repeat biopsy may be recommended if your disease appears to have progressed since the original sample was taken, if the block is too small or degraded for re-analysis, or if a new molecular test has become available that was not part of your original workup. This is a clinical decision based on your specific situation, not a routine step in changing hospitals.

Seeking a second opinion or transferring your care is your right as a patient. A responsible oncologist will support it. Some doctors express concern about continuity of treatment, which is a legitimate clinical point worth understanding — ask them what specifically worries them and whether there is a safer point in your treatment to make the move. If a doctor refuses to release your records or makes the process difficult, escalate to the hospital's patient services department. You do not need anyone's permission to seek care elsewhere.

Look first at whether the centre offers the specific treatment indicated for your cancer type and stage. Ask whether they have a multidisciplinary tumour board — a regular meeting where oncologists, surgeons, radiologists, and pathologists review each case together. ESMO and ASCO consider this the standard for complex cancer decisions. Ask how long the wait is before first-line treatment begins, and whether a dedicated coordinator manages your case. At CION, cases are reviewed by a tumour board and immunotherapy is given as day care across 35-plus centres in Telangana and Andhra Pradesh; response-assessment scans such as PET-CT are coordinated with partner imaging centres.

Yes. A second opinion at CION means your oncologist reviews your records, imaging, and pathology and gives you an independent assessment of your diagnosis and treatment plan. You can use that opinion to decide whether to continue at your current centre, modify your plan, or transfer. You do not have to move your treatment to get the opinion. Bring your tissue blocks, all imaging, and a complete treatment summary — the more complete your records, the more useful the assessment will be.